Wrapping Up International Infection Prevention Week

As International Infection Prevention Week (IIPW) winds down, we at PSQH just want to thank infection preventionists for all the hard work they do every day. In these COVID days, their job is more important than ever. Thanks to our sponsors this week, Angelini Pharma and GOJO, the inventors of Purell.

Read More »

Post-Pandemic: Be Prepared to Explain How You’re Going to Catch Up

All accreditation organizations as well as CMS are working on backlogs of surveys delayed by the public health emergency (PHE) declared in March. Waivers will no longer be allowed once that PHE is lifted. As many facilities have had their hands full with patient surges from COVID-19, the illness caused by the 2019 novel coronavirus, they’ll have work to do to ensure their environment of care is brought up to speed.

Read More »

PSQH: The Podcast Episode 14 – Infection Prevention During a Pandemic

On episode 14 of PSQH: The Podcast, host Jay Kumar talks to LRC Systems founder and CEO Dr. Shailesh Date about how U.S. hospitals have responded to COVID-19, what to expect as we enter flu season, thoughts about a potential vaccine, and the threat of co-infections. This episode is part of PSQH’s celebration of International Infection Prevention Week and is brought to you by Angelini Pharma and GOJO, the inventors of Purell.

Read More »

Mortality Data Supports Placing Seriously Ill Coronavirus Patients on ECMO

The co-authors of the recent research article wrote that the study provides “provisional support” for using ECMO to treat coronavirus patients with acute hypoxemic respiratory failure. “In ECMO-supported patients with COVID-19 and characterized as having ARDS, estimated in-hospital mortality 90 days after ECMO initiation was 38.0%, consistent with previous mortality rates in non-COVID-19 ECMO-supported patients with ARDS and acute respiratory failure.”

Read More »